| Listed site | cdmo | both |
|---|
| Summary | Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity. | Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S. |
|---|
| Services | - Cell Therapy Manufacturing
- Viral Vector Manufacturing
- AAV Manufacturing
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Formulation Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Recombinant Protein Manufacturing
- Biologics Development & Manufacturing
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Secondary Packaging & Labeling
- Stability Testing & Storage
- CMC Regulatory Submission Support
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Topical & Semi-Solid Manufacturing
- Serialization & Track-and-Trace
- Cold-Chain Storage & Logistics
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Lentiviral Vector Manufacturing
| - Discovery Research
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- GLP Toxicology
- Analytical Method Development & Validation
- Formulation Development
- Process Development
- CMC Analytical Development
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cell-Line Development
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Bioanalysis
- Peptide Manufacturing
- Oligonucleotide Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Cell Therapy Manufacturing
- mRNA Manufacturing
- Translational Research
- High-Throughput Screening
- Genetic Toxicology
- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Carcinogenicity Studies
- DART (Reproductive & Developmental Toxicology)
- Specialized & Large-Animal Models
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- ICH Stability Studies
- Companion Diagnostics Development
- Microbiology Services
- Virology Services
- Immunology & Inflammation Services
- Oncology Specialty Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science
- Device & Combination Product Services
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Microbial Fermentation
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Vaccine Manufacturing
- Microbiome / Live Biotherapeutic Manufacturing
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Technology Transfer
- Quality Control Testing
- Stability Testing & Storage
- Extractables & Leachables Studies
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Peptide
- Oligonucleotide
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
- mRNA
- Gene Therapy
- Vaccine
|
|---|
| Indications | Data not yet provided. | - Rare Disease
- Oncology
- Immunology
- Neurology
- Psychiatry
- Metabolic
- Cardiovascular
- Infectious Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Nephrology
- Women's Health
|
|---|
| Locations | - Headquarters, United States
- Asia Pacific, Asia Pacific
- Europe, Europe
- Latin America, Latin America
- North America, North America, United States
- China, China
- Japan, Japan
- North America, North America
- Global Network
| - Headquarters, Bangalore, Karnataka, India
- U.S. Biologics Facility, United States
- U.S. Biologics Facility, San Diego, California, United States
|
|---|
| Certifications | - GMP · Identifier: Nine GMP facilities
| Data not yet provided. |
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|